Vision-Related Quality of Life, Anxiety and Depression in Congolese Patients with Polypoidal Choroidal Vasculopathy

Kabedi, Nelly N.; Kayembe, D. L.; Mwanza, Jean-Claude

doi:10.1080/08820538.2020.1774623

Cited by 2 publications

(1 citation statement)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2,3 Psychiatric diseases particularly anxiety disorder, stress disorder and type A personality have been emphasized as predominant factors for CSCR. [4][5][6][7][8][9] It is known that these conditions are associated with increased steroid and catecholamine levels. 10,11 Moreover, the use of corticosteroids is the most consistent risk factor for CSCR.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of retinal and choroidal vascular structures in patients with anxiety disorder

Acan,

Baykan,

Karahan

2024

European Journal of Ophthalmology

View full text Add to dashboard Cite

Purpose To evaluate the retinal and choroidal vascular structures in patients with anxiety disorders. Methods Thirthy-four eyes of 34 patients who were diagnosed with any anxiety disorders were compared with 32 eyes of 32 age- and sex-matched controls. Central macular thickness (CMT), foveal vascular zone (FAZ) area, total retinal vascular densities of superficial and deep capillary plexus (VDSCP, VDDCP), outer retinal and choriocapillary layers (ORL, CCL) blood flow rates, central subfoveal choroidal thickness (SFCT) and choriodal vascularity index (CVI) were evaluated with optical coherence tomography angiography (OCT-A) and enhanced depth imaging optical coherence tomography (EDI-OCT). Results No statistical differences were found between the study and control groups in terms of CMT, FAZ area, VDSCP, VDDCP, ORL and CCL blood flow rates. The mean SFCT was 346.26 ± 64.26 µm in patients with anxiety disorder and was found to be statistically significantly thicker than the control group (319.56 ± 37.19 µm) ( p = 0.042). Besides, CVI was significantly lower in the study group (71.09 ± 2.64 vs 73.13 ± 3.31, p = 0.008). Conclusion In people with anxiety disorders, the SFCT was found to be thicker and CVI was found to be lower than normal subjects. Although anxiety and stress are important factors in central serous chorioretinopathy, multifactorial factors, including ocular factors, play a role in the pathophysiology of the disease. There is a need for prospective studies with larger series on the subject.

show abstract

Section: Introductionmentioning

confidence: 99%

Evaluation of retinal and choroidal vascular structures in patients with anxiety disorder

Acan,

Baykan,

Karahan

2024

European Journal of Ophthalmology

View full text Add to dashboard Cite

show abstract

The prevalence of anxiety symptoms and disorders among ophthalmic disease patients

et al. 2022

View full text Add to dashboard Cite

Background: Progressive and irreversible vision loss has been shown to place a patient at risk of mental health problems such as anxiety. However, the reported prevalence of anxiety symptoms and disorders among eye disease patients vary across studies. Thus, this study aims to clarify the estimated prevalence of anxiety symptoms and disorders among ophthalmic disease patients. Methods: Relevant studies on the prevalence of anxiety symptoms and disorders among eye disease patients were collected through international databases, PubMed, Scopus, and Web of Science. A random-effects model was used to determine the pooled prevalence of anxiety symptoms and disorders among ophthalmic disease patients. Results: The 95 included studies yielded a pooled prevalence of 31.2% patients with anxiety symptoms and 19.0% with anxiety disorders among subjects with ophthalmic disease. Pediatric patients were more anxious (58.6%) than adults (29%). Anxiety symptoms were most prevalent in uveitis (53.5%), followed by dry eye disease (DED, 37.2%), retinitis pigmentosa (RP, 36.5%), diabetic retinopathy (DR, 31.3%), glaucoma (30.7%), myopia (24.7%), age-related macular degeneration (AMD, 21.6%), and cataract (21.2%) patients. Anxiety disorders were most prevalent in thyroid eye disease (TED, 28.9%), followed by glaucoma (22.2%) and DED (11.4%). When compared with healthy controls, there was a twofold increase on the prevalence of anxiety symptoms (OR = 1.912, 95% CI 1.463–2.5, p < 0.001) and anxiety disorders (OR = 2.281, 95% CI 1.168–4.454, p = 0.016). Conclusion: Anxiety symptoms and disorders are common problems associated with ophthalmic disease patients. Thus, comprehensive and appropriate treatments are necessary for treating anxiety symptoms and disorders among ophthalmic disease patients.

show abstract

Vision-Related Quality of Life, Anxiety and Depression in Congolese Patients with Polypoidal Choroidal Vasculopathy

Cited by 2 publications

References 36 publications

Evaluation of retinal and choroidal vascular structures in patients with anxiety disorder

Evaluation of retinal and choroidal vascular structures in patients with anxiety disorder

The prevalence of anxiety symptoms and disorders among ophthalmic disease patients

Contact Info

Product

Resources

About